Status:
NOT_YET_RECRUITING
A Sequential Cohort Study Exploring GELCLAIR in the Management of Oral Mucositis in Patients Receiving Radical Radiation for Head and Neck Cancer
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Oral Mucositis Due to Radiation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if Gelclair lubricant gel can help manage Oral Mucositis (OM) among Oropharyngeal and Oral cavity cancer patients receiving radiation treatment. The main qu...
Detailed Description
Radiotherapy (RT) induced mucositis, including oral mucositis (OM), is the most common high-grade toxicity observed during high dose RT for Head and Neck Cancer (HNC). Prevention usually consists of a...
Eligibility Criteria
Inclusion
- Diagnosed with primary mucosal squamous cell carcinoma of the oropharynx or oral cavity
- Treatment plan includes at least 60Gy of daily radiotherapy, with or without concurrent chemotherapy
- Highly likely to develop OM CTCAE v5.0, grade 2
- Can read and understand English
Exclusion
- \- Patients who already have parenteral feeding tubes prescribed
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT06897215
Start Date
May 1 2025
End Date
December 31 2025
Last Update
April 9 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.